Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

ABSTRACT: Cristatella Mucedo genome sequencing

PROVIDER: PRJNA715104 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR13995307_subreads.fastq.gz	Fastqsanger.gz
	SRR13995308_subreads.fastq.gz	Fastqsanger.gz
	SRR13995309_subreads.fastq.gz	Fastqsanger.gz
	SRR13987361_subreads.fastq.gz	Fastqsanger.gz
	SRR13987362_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 6

Similar Datasets

Bulk RNA sequencing of various morphological locations and colony differentiation stages of Cristatella mucedo

Project description:RNA-sequencing of Cristatella mucedo: two dissections of mature colonies, and characterization of different developmental stages starting from frozen statoblasts.

2019-12-11 | GSE141747 | GEO

Cristatella mucedo

Project description:Cristatella mucedo overview

| PRJNA597104 | ENA

Cristatella mucedo isolate:SPBEP1

Project description:Cristatella mucedo isolate:SPBEP1 Genome sequencing and assembly

| PRJNA592440 | ENA

Cristatella mucedo

Project description:Transcriptomic landscape of polypide development in freshwater bryozoan Cristatella mucedo

| PRJNA1111906 | ENA

Bulk RNA sequencing of various morphological locations and colony differentiation stages of Cristatella mucedo

Project description:Bulk RNA sequencing of various morphological locations and colony differentiation stages of Cristatella mucedo

| PRJNA594616 | ENA

Aethia cristatella

Project description:Aethia cristatella

| PRJNA855050 | ENA

A multicenter translational biomarker phase II trial of regorafenib in patients with non-resectable pretreated colorectal cancer.

Project description:Primary objectives: The primary objective is to investigate circulating tumor DNA (ctDNA) via deep sequencing for mutation detection and by whole genome sequencing for copy number analyses before start (baseline) with regorafenib and at defined time points during administration of regorafenib for treatment efficacy in colorectal cancer patients in terms of overall survival (OS). Primary endpoints: circulating tumor DNA (ctDNA) via deep sequencing for mutation detection and by whole genome sequencing for copy number analyses before start (baseline) with regorafenib and at defined time points during administration of regorafenib for treatment efficacy in colorectal cancer patients in terms of overall survival (OS).

| 2533916 | ecrin-mdr-crc

Aethia cristatella

Project description:Aethia cristatella overview

| PRJNA855517 | ENA

Mucor mucedo strain:NRRL 3635 | isolate:NRRL 3635

Project description:Mucor mucedo NRRL 3635 Resequencing genome sequencing

| PRJNA650752 | ENA

Mucor mucedo

Project description:Mucor mucedo overview

| PRJNA520265 | ENA